Inogen, Inc. cash flow to debt ratio of -64.18% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Inogen, Inc.'s free cash flow has decreased 93.21% from $-11.18M last year to $-21.60M, signaling decreasing performance

Inogen, Inc.'s debt to equity ratio is 0.09, which means that the company's assets are healthy financed, signaling financial stability.

Inogen, Inc.'s debt has decreased relative to shareholder equity from 0.11 last year to 0.09 today, signaling strengthened financials

Inogen, Inc. has a net cash position, so leverage is healthy.

Inogen, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Inogen, Inc.'s profit margin has increased (-35.06%) in the last year from -10.69% to -6.94%, signaling increasing performance

Inogen, Inc.'s short-term assets of $198.30M exceed its short-term liabilities of $63.53M

Inogen, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Inogen, Inc.'s return on equity of -13.17%, is lower than 15.00%, indicating bad performance

Inogen, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Inogen, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Inogen, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Inogen, Inc. has negative free cash flow, indicating cash burn

Inogen, Inc.'s yearly earnings has increased -36.62% since last year from $-35.89M to $-22.75M, signaling increasing performance

Inogen, Inc.'s yearly revenue has increased 3.86% since last year from $335.70M to $348.67M, signaling increasing performance

ROIC -13.35% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Inogen, Inc.'s 3-year revenue CAGR of -2.59% is negative, indicating declining revenue over the past 3 years

Inogen, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Inogen, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Inogen, Inc. has insufficient data to evaluate this check.

Inogen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Inogen, Inc. is overvalued relative to its fair value price of 2.47 based on EBITDA multiple model

Inogen, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Inogen, Inc. is overvalued relative to its fair value price of -17.28 based on Earnings Fair Value model

Inogen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Inogen, Inc. has a price-to-book ratio of 0.93x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Inogen, Inc. has a price-to-sales ratio of 0.46x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue